The recommendation for Enflonsia is indicated for respiratory syncytial virus prevention in infants under eight months of age ...

He claimed that Gavi had “ignored the science” about vaccine safety. He had already dismissed all seventeen members of the ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine. What to know.

For infants undergoing cardiac surgery with cardiopulmonary bypass during or entering their first RSV season, an additional 105 mg dose is recommended as soon as the infant is stable after surgery.

RSV leads to over 100,000 infant deaths annually, but WHO’s latest guidance recommends maternal vaccines and monoclonal antibodies like nirsevimab to protect newborns, especially in low-resource ...

An antibody treatment for respiratory syncytial virus (RSV) appears to be more effective at protecting infants from severe illness than vaccination during pregnancy.

WHO Endorses First-Ever RSV Vaccination Guidance to Protect Infants The announcement comes as part of WHO’s broader effort to reduce child mortality, particularly in low- and middle-income countries ...

Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect infants against respiratory syncytial virus (RSV) – the leading cause of ...

Widespread use of maternal RSV vaccination and nirsevimab during the 2024–2025 U.S. RSV season led to a significant reduction in RSV-associated hospitalizations among infants aged 0–7 months ...

New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the importance of timely vaccination and nirsevimab administration.

RSV-associated hospitalizations for children aged 8-19 months or 20-59 months were not significantly different between the two time periods, and slightly higher in the 2024-2025 period.